The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers
Open accessAbstract
Tau is a microtubule-associated protein well known for its stabilization of microtubules in axons. Recently, it has emerged that tau participates in synaptic function as part of the molecular pathway leading to amyloid-beta (Aβ)-driven synaptotoxicity in the context of Alzheimer's disease. Here, we report the implication of tau in the profound functional synaptic modification associated with synaptic plasticity. By exposing murine cultured cortical neurons to a pharmacological synaptic activation, we induced translocation of endogenous tau from the dendritic to the postsynaptic compartment. We observed similar tau translocation to the postsynaptic fraction in acute hippocampal slices subjected to long-term potentiation. When we performed live confocal microscopy on cortical neurons transfected with human-tau-GFP, we visualized an activity-dependent accumulation of tau in the postsynaptic density. Coprecipitation using phalloidin revealed that tau interacts with the most predominant cytoskeletal component present, filamentous actin. Finally, when we exposed cortical cultures to 100 n m human synthetic Aβ oligomers (Aβo's) for 15 min, we induced mislocalization of tau into the spines under resting conditions and abrogated subsequent activity-dependent synaptic tau translocation. These changes in synaptic tau dynamics may rely on a difference between physiological and pathological phosphorylation of tau. Together, these results suggest that intense synaptic activity drives tau to the postsynaptic density of excitatory synapses and that Aβo-driven tau translocation to the spine deserves further investigation as a key event toward synaptotoxicity in neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aβ exposure modifies Tau’s phosphorylation status and prevents it from relocalizing away from the post-synaptic domain following synaptic activation [29].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vivo, tau co-localizes with actin in differentiating PC12 cells22 and in the post-synaptic compartments of mature neurons23.”
From Tau co-organizes dynamic microtubule and actin networks (2015) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“Recent studies demonstrate that tau is also present in dendrites and postsynaptic compartments [128–130].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [129]
In the citing paper
“Dendritic tau may also play a role in regulating synaptic plasticity, as synaptic activity can recruit tau to the postsynaptic densities, where tau deletion in various mouse models show deficits either in LTP or LTD [129, 131, 132].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588
Lifeact: a versatile marker to visualize F-actin
Riedl, J., Crevenna, A. H., Kessenbrock, K., Yu, J. H., Neukirchen, D., Bista, M., Bradke, F., Jenne, D., Holak, T. A., Werb, Z., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1220 · Cited by 2,189
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Impaired Long-Term Potentiation, Spatial Learning, and Hippocampal Development in fyn Mutant Mice
Grant, S. G. N., O’Dell, T. J., Karl, K. A., Stein, P. L., Soriano, P. M., & Kandel, E. R. (1992) · Science · doi:10.1126/science.1361685 · Cited by 1,160
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 272
Wen, G., Yao, H., Li, Y., Ding, R., Ren, X., Tan, Y., Ren, W., Yu, H. Q., Zhan, X., Wang, X., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00287 · Cited by 44
Amadoro, G., Latina, V., Corsetti, V., & Calissano, P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165584 · Cited by 44
Plácido, A. I., Pereira, C., Correira, S. C., Carvalho, C., Oliveira, C. R., & Moreira, P. I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9640-1 · Cited by 41
GSK3α, not GSK3β, drives hippocampal NMDAR‐dependent LTD via tau‐mediated spine anchoring
Draffin, J. E., Sánchez‐Castillo, C., Fernández‐Rodrigo, A., Sánchez‐Sáez, X., Ávila, J., Wagner, F. F., & Esteban, J. A. (2020) · The EMBO Journal · doi:10.15252/embj.2020105513 · Cited by 39
Hirota, Y., Sakakibara, Y., Ibaraki, K., Takei, K., Iijima, K., & Sekiya, M. (2022) · Brain Communications · doi:10.1093/braincomms/fcac286 · Cited by 41
Recent Insights on Alzheimer’s Disease Originating from Yeast Models
Seynnaeve, D., Vecchio, M. D., Fruhmann, G., Verelst, J., Cools, M., Beckers, J., Mulvihill, D. P., Winderickx, J., & Franssens, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071947 · Cited by 39
Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model
Manucat-Tan, N. B., Shen, L.-L., Bobrovskaya, L., Al‐Hawwas, M., Zhou, F. H., Wang, Y., & Zhou, X. (2019) · Aging · doi:10.18632/aging.102202 · Cited by 36
Rolland, M., Powell, R., Jacquier‐Sarlin, M. R., Boisseau, S., Reynaud-Dulaurier, R., Hernández, J. M., André, L., Borel, E., Buisson, A., & Lanté, F. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2501-19.2020 · Cited by 41
Self-citationPadilla-Godínez, F. J., Vázquez-García, E. R., Trujillo-Villagrán, M. I., Soto-Rojas, L. O., Palomero‐Rivero, M., Hernández-González, O., Pérez-Eugenio, F., Collazo-Navarrete, O., Arias-Carrión, Ó., & Guerra‐Crespo, M. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1570553 · Cited by 42
Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer’s Disease
Yin, X., Zhao, C., Qiu, Y., Zhou, Z., Bao, J., & Qian, W. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.671779 · Cited by 41
Wennagel, D., Braz, B. Y., Capizzi, M., Barnat, M., & Humbert, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111261 · Cited by 36
Peris, L., Bisbal, M., Hernández, J. M., Saoudi, Y., Jonckheere, J., Rolland, M., Sébastien, M., Brocard, J., Denarier, É., Bosc, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05869-z · Cited by 37
Self-citationGlennon, E. B. C., Lau, D. H. W., Gabriele, R. M. C., Taylor, M. F., Troakes, C., Opie-Martin, S., Elliott, C., Killick, R., Hanger, D. P., Perez‐Nievas, B. G., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa011 · Cited by 36
Carroll, T., Guha, S. K., Nehrke, K. W., & Johnson, G. V. W. (2021) · Biology · doi:10.3390/biology10101047 · Cited by 39
Tau; One Protein, So Many Diseases
Tabeshmehr, P., & Eftekharpour, E. (2023) · Biology · doi:10.3390/biology12020244 · Cited by 33
Balaji, V., Kaniyappan, S., Mandelkow�, E., Wang, Y., & Mandelkow, E.-M. (2018) · Autophagy · doi:10.1080/15548627.2018.1509607 · Cited by 33
Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin
Bruyère, J., Abada, Y.-S. K., Vitet, H., Fontaine, G., Deloulme, J., Cès, A., Denarier, É., Pernet‐Gallay, K., Andrieux, A., Humbert, S., et al. (2020) · eLife · doi:10.7554/elife.56371 · Cited by 38
Stojakovic, A., Chang, S.-Y., Nesbitt, J. J., Pichurin, N. P., Ostroot, M., Aikawa, T., Kanekiyo, T., & Trushina, E. V. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201015 · Cited by 31
A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity
Rush, T., Roth, J. R., Thompson, S. J., Aldaher, A. R., Cochran, J. N., & Roberson, E. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104668 · Cited by 30
Self-citationKokras, N., Sotiropoulos, I., Besinis, D., Tzouveka, E. L., Almeida, O. F. X., Sousa, N., & Dalla, C. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.1107 · Cited by 31
Cai, N., Chen, J., Bi, D., Gu, L., Yao, L., Li, X., Li, H., Xu, H. Y., Hu, Z., Liu, Q., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07022 · Cited by 29
Regan, P. L., Mitchell, S. J., Kim, S. C., Lee, Y., Yi, J. H., Barbati, S. A., Shaw, C. E., & Cho, K. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.3129-20.2021 · Cited by 29
Teravskis, P. J., Ashe, K. H., & Liao, D. (2020) · The Neuroscientist · doi:10.1177/1073858420916696 · Cited by 31
Verstraelen, P., Detrez, J. R., Verschuuren, M., Kuijlaars, J., Nuydens, R., Timmermans, J., & Vos, W. H. D. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00173 · Cited by 28
Kilinc, D., Vreulx, A.-C., Mendes, T., Flaig, A., Coelho, D. M., Verschoore, M., Demiautte, F., Amouyel, P., Bank, N.-C. B., Eysert, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa139 · Cited by 34
Tournier, B. B., Barca, C., Fall, A. B., Gloria, Y., Meyer, L., Ceyzériat, K., & Millet, P. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12712 · Cited by 29
Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice
Walker, C. K., Greathouse, K. M., Boros, B. D., Poovey, E. H., Clearman, K. R., Ramdas, R., Muhammad, H. M., & Herskowitz, J. H. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2020.12.006 · Cited by 27
Macromolecular Structures and Proteins Interacting with the Microtubule Associated Tau Protein
Jiménez, J. S. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.05.023 · Cited by 28
The Synaptic Dysregulation in Adolescent Rats Exposed to Maternal Immune Activation
Cieślik, M., Gąssowska-Dobrowolska, M., Zawadzka, A., Frontczak‐Baniewicz, M., Gewartowska, M., Dominiak, A., Czapski, G. A., & Adamczyk, A. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.555290 · Cited by 25
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
Pawlowski, M., Meuth, S., & Duning, T. (2017) · Diagnostics · doi:10.3390/diagnostics7030042 · Cited by 25
Fyn Kinase in Alzheimer’s Disease: Unraveling Molecular Mechanisms and Therapeutic Implications
Meur, S., & Karati, D. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04286-2 · Cited by 24
Sidoryk‐Wȩgrzynowicz, M., Adamiak, K., & Strużyńska, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212448 · Cited by 26
Melatonin in Synaptic Impairments of Alzheimer’s Disease
Shi, Y., Fang, Y., Wei, Y., Jiang, Q., Zeng, P. H., Tang, N., Lu, Y., & Tian, Q. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171178 · Cited by 24
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease
Stancu, I., Ferraiolo, M., Terwel, D., & Dewachter, I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_13 · Cited by 23
Rankovic, M., & Zweckstetter, M. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.014 · Cited by 25
Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Wysocka, A., Pałasz, E., Steczkowska, M., & Niewiadomska, G. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200424134311 · Cited by 24
Heparan Sulfate Proteoglycans in Tauopathy
Zhu, Y., Gandy, L. A., Zhang, F., Liu, J., Wang, C., Blair, L. J., Linhardt, R. J., & Wang, L. (2022) · Biomolecules · doi:10.3390/biom12121792 · Cited by 27
Selective impact of Tau loss on nociceptive primary afferents and pain sensation
Sotiropoulos, I., Lopes, A. T., Pinto, V., Lopes, S., Carlos, S., Duarte-Silva, S., Neves-Carvalho, A., Pinto-Ribeiro, F., Pinheiro, S., Fernandes, R., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.008 · Cited by 23
Buchholz, S., Kabbani, M. A. A., Bell‐Simons, M., Kluge, L., Cagmak, C., Klimek, J., Haag, N., Iohan, L. D. C. C., Coulon, A., Costa, M. R., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14403 · Cited by 21
Age‐dependent NMDA receptor function is regulated by the amyloid precursor protein
Rajão‐Saraiva, J., Dunot, J., Ribera, A., Temido‐Ferreira, M., Coelho, J. E., König, S., Moréno, S., Enguita, F. J., Willem, M., Kins, S., et al. (2023) · Aging Cell · doi:10.1111/acel.13778 · Cited by 25
Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies
McKenzie-Nickson, S., Chan, J., Perez, K. A., Hung, L. W., Cheng, L., Sedjahtera, A., Gunawan, L., Adlard, P. A., Hayne, D. J., McInnes, L. E., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00161 · Cited by 22
Dávila-Bouziguet, E., Fabra, G. T., Ávila, J., Soriano, E., & Pascual, M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.006 · Cited by 23
Martínez‐Mármol, R., Small, C., Jiang, A., Palliyaguru, T., Wallis, T. P., Gormal, R. S., Sibarita, J., Götz, J., & Meunier, F. A. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01825-y · Cited by 21
Hanger, D. P., Goniotaki, D., & Noble, W. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_9 · Cited by 23
Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction
Siano, G., Falcicchia, C., Origlia, N., Cattaneo, A., & Primio, C. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810145 · Cited by 22
Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington’s Disease Brain
Petry, S., Nateghi, B., Keraudren, R., Sergeant, N., Planel, E., Hébert, S. S., & St‐Amour, I. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.014 · Cited by 20
Moosecker, S., Gomes, P., Dioli, C., Yu, S., Sotiropoulos, I., & Almeida, O. F. X. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00239 · Cited by 20
A TIRF microscopy assay to decode how tau regulates EB’s tracking at microtubule ends
Ramírez‐Ríos, S., Serre, L., Stoppin‐Mellet, V., Prezel, E., Vinit, A., Courriol, E., Fourest‐Lieuvin, A., Delaroche, J., Denarier, É., & Arnal, I. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.013 · Cited by 22
Self-citationMüller-Thomsen, L., Borgmann, D., Morcinek, K., Schröder, S. L., Dengler, B., Moser, N., Neumaier, F., Schneider, T., Schröder, H., & Huggenberger, S. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.007 · Cited by 19
Monteiro‐Fernandes, D., Sousa, N., Almeida, O. F. X., & Sotiropoulos, I. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.049 · Cited by 19
Torres-Cruz, F. M., Rodríguez-Cruz, F., Escobar-Herrera, J., Barragán-Andrade, N., Basurto-Islas, G., Ripova, D., Ávila, J., & Garcia-Sierra, F. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150396 · Cited by 19
Alzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19
Sun, H., Xu, L., Wang, K., Li, Y., Bai, T., Dong, S., Wu, H., & Yao, Z. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00460 · Cited by 17
A review of the roles of pathogens in Alzheimer’s disease
Zhao, M., Wang, Y., Shen, Y., Wei, C., Zhang, G., & Sun, L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1439055 · Cited by 18
Babür, E., Tan, B., Delibaş, S., Yousef, M., Dursun, N., & Süer, C. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1224-x · Cited by 16
Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Liu, X., Zhang, N., Zhang, S., & Xu, P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15502 · Cited by 16
Essis, S. A., Laurier-Laurin, M.-É., Pépin, É., Cyr, M., & Massicotte, G. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.055 · Cited by 16
Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain
Kubo, A., Ueda, S., Yamane, A., Wada‐Kakuda, S., Narita, M., Matsuyama, M., Nomori, A., Takashima, A., Kato, T., Onodera, O., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2845-18.2019 · Cited by 17
CSF total tau as a proxy of synaptic degeneration
Soares, C., Bellaver, B., Ferreira, P. C. L., Povala, G., Aguzzoli, C. S., Ferrari‐Souza, J. P., Zalzale, H., Lussier, F. Z., Rohden, F., Abbas, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63545-5 · Cited by 19
Tau here, tau there, tau almost everywhere: Clarifying the distribution of tau in the adult CNS
Kanaan, N. M. (2024) · Cytoskeleton · doi:10.1002/cm.21820 · Cited by 15
Rather, M. A., Khan, A., Jahan, S., Siddiqui, A. J., & Wang, L. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.042 · Cited by 18
Wu, Z., Bai, L., Tu, R., Zhang, L., Ba, Y., Zhang, H., Li, X., Cheng, X., Li, W., & Huang, H. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103350 · Cited by 15
Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R
Ackmann, J., Brüge, A., Gotina, L., Lim, S., Jahreis, K., Vollbrecht, A.-L., Kim, Y. K., Pae, A. N., Labus, J., & Ponimaskin, E. G. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01612-y · Cited by 14
Hibernation Impairs Odor Discrimination – Implications for Alzheimer’s Disease
Bullmann, T., Feneberg, E., Kretzschmann, T. P., Ogunlade, V., Holzer, M., & Arendt, T. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00069 · Cited by 13
A Connected Network of Interacting Proteins Is Involved in Human-Tau Toxicity in Drosophila
Feuillette, S., Charbonnier, C., Frébourg, T., Campion, D., & Lecourtois, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00068 · Cited by 14
Hirota, Y., Sakakibara, Y., Morishima, M., Sano, T., Hara, M., Arakawa, A., Takao, M., Murayama, S., Saito, Y., Sekiya, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116203 · Cited by 15
Microtubule Organization and Microtubule-Associated Proteins (MAPs)
Tortosa, E., Kapitein, L. C., & Hoogenraad, C. C. (2016) · Springer eBooks · doi:10.1007/978-4-431-56050-0_3 · Cited by 13
Khan, R. I., Nirzhor, S. S. R., & Rashid, B. (2018) · Brain Sciences · doi:10.3390/brainsci8090162 · Cited by 12
Functional characterisation of filamentous actin probe expression in neuronal cells
Patel, S., Fok, S., Stefen, H., Tomanić, T., Parić, E., Herold, R., Brettle, M., Djordjevic, A., & Fath, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187979 · Cited by 12
Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction
Fan, X., Xia, L., Zhou, Z., Qiu, Y., Zhao, C., Yin, X., & Qian, W. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.908881 · Cited by 14
Alix is required for activity-dependent bulk endocytosis at brain synapses
Laporte, M. H., Il, K., Caudal, L. C., Zhao, N., Schwarz, Y. N., Rolland, M., Hernández, J. M., Martineau, M., Chatellard, C., Denarier, É., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001659 · Cited by 11
Self-citationKootar, S., Frandemiche, M., Dhib, G., Mouska, X., Lorivel, T., Poupon, G., Hunt, H., Tronche, F., Bethus, I., Barik, J., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.001 · Cited by 11
Self-citationSun, K. T., & Mok, S. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00512 · Cited by 12
Fertan, E., Meisl, G., & Klenerman, D. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70462 · Cited by 10
Do Sleep Disturbances have a Dual Effect on Alzheimer’s Disease?
Arjmandi-Rad, S., Ebrahimnejad, M., Zarrindast, M., & Vaseghi, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01228-1 · Cited by 11
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
Haut, F., Argyrousi, E. K., & Arancio, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010259 · Cited by 11
Duan, Y., Zhou, S., Ma, J., Yin, P., & Cao, X. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13008 · Cited by 10
Nižetić, D., Chen, C., Hong, W., & Koo, E. H. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00299 · Cited by 9
Dynamics of microtubules and their associated proteins
Benarroch, E. E. (2016) · Neurology · doi:10.1212/wnl.0000000000002686 · Cited by 9
Symmetric and Asymmetric Synapses Driving Neurodegenerative Disorders
Romaus‐Sanjurjo, D., Custodia, A., Aramburu-Núñez, M., Posado-Fernández, A., Vázquez‐Vázquez, L., Camino-Castiñeiras, J., Leira, Y., Peleteiro, J. M. P., Aldrey, J. M., Ouro, A., et al. (2021) · Symmetry · doi:10.3390/sym13122333 · Cited by 8
Célestine, M., Jacquier‐Sarlin, M. R., Borel, E., Petit, F., Lanté, F., Bousset, L., Hérard, A., Buisson, A., & Dhénain, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02611-8 · Cited by 7
Self-citationTracking Tau in Neurons: How to Transfect and Track Exogenous Tau into Primary Neurons
Zempel, H., Luedtke, J., & Mandelkow, E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_21 · Cited by 8
Kedia, S., Fertan, E., Wu, Y., Zhang, Y. P., Meisl, G., Lam, J. Y. L., Wiseman, F. K., McEwan, W. A., Quaegebeur, A., Spillantini, M. G., et al. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.01.001 · Cited by 7
The Role of Tau in the Post-synapse
Regan, P. L., & Cho, K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_10 · Cited by 7
Prezel, E., Stoppin‐Mellet, V., Elie, A., Zala, N., Denarier, É., Serre, L., & Arnal, I. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.012 · Cited by 7
Self-citationAtwa, A., Alhadidy, M. M., Lamp, J. A., Combs, B., & Kanaan, N. M. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00473 · Cited by 6
Crimins, J. L., Puri, R., Calakos, K. C., Yuk, F., Janssen, W. G. M., Hara, Y., Rapp, P. R., & Morrison, J. H. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24576 · Cited by 6
Making tau amyloid models in vitro: a crucial and underestimated challenge
Broc, J., Piersson, C., & Fichou, Y. (2025) · FEBS Letters · doi:10.1002/1873-3468.70022 · Cited by 5
Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances
Ren, J., Xie, H., Weng, Y., Ge, Y., Yao, R., Jiang, Z., Zhang, J., Zhu, Y., Fu, X., Wang, J., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03766-5 · Cited by 5
Hettinger, J. C., & Cirrito, J. R. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.008 · Cited by 5
Xu, W., Zang, Y., Shen, Q., Shan, Y., Han, B., Zhou, H., & Lai, X. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146377 · Cited by 5
Süer, C., Demircan, N. Y., Barutçu, Ö., Tan, B., & Dursun, N. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00254-y · Cited by 5
The cytoskeleton in ‘couch potato-ism’: Insights from a murine model of impaired actin dynamics
Gertz, K. R., Uhlemann, R., Foryst‐Ludwig, A., Barrientos, R. M., Kappert, K., Thöne‐Reineke, C., Djoufack, P. C., Kirschbaum, C., Fink, K., Heinz, A., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.04.004 · Cited by 4
Mavroeidi, P., Mavrofrydi, O., Pappa, E., Panopoulou, M., Papazafiri, P., Haralambous, S., & Efthimiopoulos, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170157 · Cited by 4
Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism
Vitale, C., Jaudon, F., Luján, R., Bartolucci, M., Celora, L., Reisoli, E., Ruggeri, R., Petretto, A., Thalhammer, A., & Cingolani, L. A. (2025) · Brain · doi:10.1093/brain/awaf089 · Cited by 3
Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer’s disease
Fan, X., Wang, H., Ping, J., Li, M., Gu, J., & Qian, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117401 · Cited by 8
Russotto, A., Longobardi, A., Ciullini, A., Cazzaniga, F. A., Bacınoğlu, M. B., Borroni, B., Ghidoni, R., Moda, F., & Saraceno, C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07471-6 · Cited by 5
Early synaptic pathology is associated with small tau aggregates in Alzheimer’s disease
Fertan, E., Kedia, S., Nolan, G., Meisl, G., Cotton, M. W., Müller, K. H., Zhang, Z., Mureşan, L., Quaegebeur, A., Spillantini, M. G., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02977-9 · Cited by 3
Xu, H., Wang, G., Jiang, Z., Han, Y., Zhao, W., Zhang, H., Liu, H., Liu, H., Li, Z., & Ji, F. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500941 · Cited by 3
Neurochemical Aspects of Alzheimer’s Type of Dementia
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00003-9 · Cited by 4
Metadata
- Authors
- Frandemiche, M. L., De Seranno, S., Rush, T., Borel, E., Elie, A., Arnal, I., Lanté, F., & Buisson, A.
- Affiliations
- Inserm (FR)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2014-04-23
- Volume
- 34
- Issue
- 17
- Pages
- 6084-6097
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6608293
- OpenAlex
- W2006955217
- Cited by
- 272
- References
- 48
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 27 · 2023: 9 · 2022: 18 · 2021: 30 · 2020: 29 · 2019: 26 · 2018: 32 · 2017: 23 · 2016: 25 · 2015: 18 · 2014: 3
- FWCI
- 15.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondation Neurodis
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, amyloid-beta oligomers, synaptic plasticity, postsynaptic density, excitatory synapses, synaptotoxicity, Alzheimer's disease, long-term potentiation, actin, tau phosphorylation, dendritic spines, cortical neurons, hippocampus
- MeSH terms
- Animals, Cells, Cultured, Cerebral Cortex, Dendrites, Neurons, Peptide Fragments, Phosphorylation, Synapses, Amyloid beta-Peptides, tau Proteins, Protein Transport, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
